| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.3M | +8.0% | -31.2% |
| Cost of Revenue | $16.4M | +1.8% | -26.2% |
| R&D Expense | $310K | -29.9% | -72.2% |
| SG&A Expense | $4.2M | -26.5% | -19.9% |
| Operating Income | -$2.0M | +57.3% | +61.8% |
| Pre-tax Income | -$4.1M | +27.8% | +27.3% |
| Income Tax | $16K | -60.0% | +6.7% |
| Net Income | -$4.1M | +26.6% | +22.3% |
| EPS (Basic) | -$0.37 | +28.8% | -516.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.6M | -26.4% | -20.5% |
| Accounts Receivable | $9.8M | +28.7% | +12.1% |
| Inventory | $1.4M | -3.1% | -13.3% |
| Current Assets | $21.2M | -5.0% | -6.9% |
| Total Assets | $52.3M | -2.9% | -7.0% |
| Current Liabilities | $39.3M | +10.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.5M | — | — |
| Capital Expenditures | $2.5M | — | — |
| Investing Cash Flow | -$7.5M | — | — |
| Financing Cash Flow | $20.5M | — | — |
| Free Cash Flow | -$11.0M | — | — |
| -3.9% |
| Total Liabilities | $62.8M | +1.6% | +14.0% |
| Stockholders' Equity | -$19.0M | -16.9% | -124.7% |